SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Feb 21, 2017 8-K
SC 13G Feb 17, 2017 SC 13G
SC 13G Feb 17, 2017 SC 13G
SC 13G Feb 15, 2017 SABBY 13G GALE 2.15.17
4 Feb 10, 2017 GALENA BIOPHARMA, INC.
3 Feb 10, 2017 GALENA BIOPHARMA, INC.
8-K Feb 10, 2017 8-K
SC 13G/A Feb 10, 2017 SC 13G/A
424B5 Feb 9, 2017 424B5
4 Feb 7, 2017 PRIMARY DOCUMENT
424B2 Feb 7, 2017 424B2
8-K Feb 7, 2017 8-K
8-K Jan 31, 2017 8-K
SC 13G Jan 30, 2017
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 24, 2017 PRIMARY DOCUMENT
4 Jan 19, 2017 PRIMARY DOCUMENT
4 Jan 19, 2017 PRIMARY DOCUMENT
4 Jan 19, 2017 PRIMARY DOCUMENT
SC 13G/A Jan 11, 2017 SABBY 13G-A GALE 1.11.17
← Newer Page 23 of 51 · 1272 filings Older →